Skip to content
LinkedIn
Search
Search
The Business of Biofabrication
News
Perspectives
Learn
Landscape
Ricky Solorzano
April 30, 2026
Eli Lilly Pays Up to $7B for Kelonia’s In Vivo CAR-T Platform and What It Means for Cell Therapy Manufacturing
Ricky Solorzano
April 29, 2026
OHSU Secures $9.2M NIH Grant to Advance Bone Cancer Organs-on-Chips Research
Ricky Solorzano
April 27, 2026
The Organ-on-Chip, Microphysiological Systems Landscape, NAMs: A Business Overview
Ricky Solorzano
April 24, 2026
Linton Lifesciences Launches Biofabricated NAMs: Rebuilding the Missing Layer Between Biology and Decision-Making
Ricky Solorzano
April 21, 2026
ARPA-H Is Funding the Regeneration of Human Joints, and the Biofabrication Implications Go Further Than Osteoarthritis
Ricky Solorzano
April 9, 2026
The $150 Bioprinter Extruder That Anyone Can Build
Ricky Solorzano
April 8, 2026
Cellbricks Therapeutics Raises €10M to Advance Biofabricated Tissue Implants for Wound Care and Reconstructive Surgery
Ricky Solorzano
April 6, 2026
NAMs, New Approach Methodologies for Drug Discovery: What It Means for the Future of Alternatives to Animal Testing and Biofabrication
Ricky Solorzano
April 5, 2026
Canada Just Bet Another $280M on Bioprinted Medicines, Here’s What It Means for the Industry
Ricky Solorzano
March 8, 2026
UC San Diego’s ARPA-H Project Targets the A Different Approach for the Bioprinted LIVER Program
Ricky Solorzano
Previous Page
1
2
3
4
5
…
16
Next Page
Archives
Subscribe
Subscribed
The Business of Biofabrication
Sign me up
Have a WordPress.com account?
Log in now.
The Business of Biofabrication
View site in Reader
Manage subscriptions
Sign up
Log in
Report this content
Collapse this bar
